Tuesday, March 9, 2021:
E. Magnus Ohman, MD, FRCPI, FESC, FACC, FSCAI
Professor of Medicine
The Kent and Siri Rawson Director, Duke Program for Advanced Coronary Disease
Associate Director, Duke Heart Center, Duke University Medical Center
This event will be held online. Meeting information is below.
Myocardial Infarction Cardiogenic Shock in 2021: How Can We Improve Outcomes?
- Discuss management of cardiogenic shock and outcomes
- Define optimal care of cardiogenic shock based on clinical trials
- Discuss a heart-team-based approach for the management of cardiogenic shock
Join Zoom Meeting: https://inova.zoom.us/j/93146609731?pwd=Vk1RSTQ1V2NyOGlEY1QvMUZxZlR2QT09
Meeting ID: 931 4660 9731
One tap mobile
+19292056099,,93146609731#,,,,0#,,183789# US (New York)
+13017158592,,93146609731#,,,,0#,,183789# US (Germantown)
Dr. Magnus Ohman is Professor of Medicine at Duke University Medical Center and received medical degrees from the Royal College of Surgeons in Ireland and the National University of Ireland. He completed his training in cardiology at Duke University, after which he remained on staff there. In 2001, he became Chief of Cardiology at the University of North Carolina at Chapel Hill, where he founded the UNC Heart Center and became its first director. In 2005, he returned to Duke to pursue his interest in advanced coronary disease as the Director of the Program for Advanced Coronary Disease. Since that time, he has been appointed to Associate Director of the Duke Heart Center, the Kent and Siri Rawson Director for the Program for Advanced Coronary Disease, and most recently, Vice-Chair of Development and Innovation in the Department of Medicine.
Dr. Ohman’s clinical and research interests include interventional cardiology, high-risk supported PCI and treatment of patients with advanced/complex coronary disease. He has researched ways to improve patient care through the use of guidelines-based therapies and adherence and examining global cardiovascular risk and health. He has been a participant on numerous guidelines-writing committees, served on the ACC/AHA oversight committee for guidelines development, and served on the steering committees for trials on ST-elevation myocardial infarction and non-ST-elevation ACS. He is a consultant to the National Institutes of Health and a consultant for the U.S. Food and Drug Administration’s Advisory Panel for Cardiovascular Devices.
Dr. Ohman has published more than 600 peer-reviewed papers and three books in cardiovascular medicine. He holds three U.S. patents in reperfusion therapy. He is an associate editor for the Journal of the American College of Cardiology and the American Heart Journal, and he serves on the editorial boards of the Journal of the American College of Cardiology and the American Journal of Cardiology. He is a Fellow of the Royal College of Physicians in Ireland, the Royal Society of Medicine (U.K.), the European Society of Cardiology, the Society of Cardiac Angiography and Interventions, and the American College of Cardiology.
This is a CME Accredited Program.
Join the IHVI Center for Education Community
At Inova Heart and Vascular Institute we are dedicated to providing informative and thought provoking education with physicians, nurses, and medical professionals worldwide. Our activities are designed to enhance the professional development of the medical community by providing high-quality, innovative educational programs that improve clinical performance, and promote life-long learning. Through lectures, case studies, and participant-faculty interactions, attendees will be exposed to cutting-edge educational content and the latest advances in cardiology.